WVE Wave Life Sciences, Inc.
Nasdaq · SEC CIK 1631574 · EDGAR
- Bought, last 12 months
- $82.56M 3 purchases by 2 insiders
- Sold, last 12 months
- $16.18M 19 sales by 11 insiders
- Filings on record
- 123 since 2021-08-18, latest 2026-08-13 21:00
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | $54.63M | — |
| GSK plc | 10% | $27.93M | — |
| Francis Chris | See Remarks | — | $7.10M |
| Moran Kyle | CFO | — | $4.15M |
| Tan Aik Na | Dir | — | $1.83M |
| HENRY CHRISTIAN O | Dir | — | $1.37M |
| Rawcliffe Adrian | Dir | — | $806.6K |
| Verdine Gregory L. | Dir | — | $269.5K |
| Wagner Heidi L | Dir | — | $231.1K |
| CORRIGAN MARK | Dir | — | $217.3K |
Transactions 109
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-06 | 2022-05-05 | WVE | BOLNO PAUL | Pres, CEO, Dir | S - Sale | $1.72 | -33.5K | 436.8K | -7% | -$57.6K | |
| 2022-05-06 | 2022-05-04 | WVE | BOLNO PAUL | Pres, CEO, Dir | A - Grant | $0.00 | +92.5K | 470.3K | +24% | $0 | |
| 2022-05-06 | 2022-05-04 | WVE | Moran Kyle | CFO | A - Grant | $0.00 | +15.0K | 89.6K | +20% | $0 | |
| 2022-05-06 | 2022-05-05 | WVE | Moran Kyle | CFO | S - Sale | $1.72 | -5,021 | 84.6K | -6% | -$8,636 | |
| 2022-02-18 | 2022-02-16 | WVE | Moran Kyle | CFO | S - Sale | $2.31 | -9,204 | 74.6K | -11% | -$21.3K | |
| 2022-02-18 | 2022-02-16 | WVE | Francis Chris | See Remarks | S - Sale | $2.31 | -10.1K | 68.3K | -13% | -$23.4K | |
| 2022-02-18 | 2022-02-16 | WVE | BOLNO PAUL | Pres, CEO, Dir | S - Sale | $2.32 | -33.1K | 377.8K | -8% | -$76.9K | |
| 2022-02-18 | 2022-02-16 | WVE | Vargeese Chandra | CTO | S - Sale | $2.32 | -10.6K | 77.8K | -12% | -$24.6K | |
| 2022-02-18 | 2022-02-16 | WVE | Panzara Michael A. | See Remarks | S - Sale | $2.31 | -10.6K | 75.8K | -12% | -$24.5K |
Purchase Sale Sale after option exercise All abbreviations